Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair

被引：176

作者：

Lu, Yanxin ^{[1
]}

Kwintkiewicz, Jakub ^{[2
,3
]}

Liu, Yang ^{[1
]}

Tech, Katherine ^{[4
]}

Frady, Lauren N. ^{[2
,3
]}

Su, Yu-Ting ^{[1
]}

Bautista, Wendy ^{[1
]}

Moon, Seog In ^{[1
]}

MacDonald, Jeffrey ^{[4
]}

Ewend, Matthew G. ^{[2
,3
]}

Gilbert, Mark R. ^{[1
]}

Yang, Chunzhang ^{[1
]}

Wu, Jing ^{[1
,2
,3
]}

机构：

[1] NCI, Neurooncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[2] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[3] Univ North Carolina Chapel Hill, Dept Neurosurg, Chapel Hill, NC USA

[4] Univ North Carolina Chapel Hill, Sch Med, Dept Biomed Engn, Chapel Hill, NC USA

来源：

CANCER RESEARCH | 2017年 / 77卷 / 07期

关键词：

MUTANT IDH1; ISOCITRATE DEHYDROGENASE; OLIGODENDROGLIAL TUMORS; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA CELLS; PHASE-III; MUTATIONS; CANCER; INHIBITOR; SURVIVAL;

D O I：

10.1158/0008-5472.CAN-16-2773

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mutations in isocitrate dehydrogenase (IDH) are the most prevalent genetic abnormalities in lower grade gliomas. The presence of these mutations in glioma is prognostic for better clinical outcomes with longer patient survival. In the present study, we found that defects in oxidative metabolism and 2-HG production confer chemosensitization in IDH1-mutated glioma cells. In addition, temozolomide (TMZ) treatment induced greater DNA damage and apoptotic changes in mutant glioma cells. The PARP1-associated DNA repair pathway was extensively compromised in mutant cells due to decreased NAD_ availability. Targeting the PARP DNA repair pathway extensively sensitized IDH1-mutated glioma cells to TMZ. Our findings demonstrate a novel molecular mechanism that defines chemosensitivity in IDH-mutated gliomas. Targeting PARP-associated DNA repair may represent a novel therapeutic strategy for gliomas.

引用

页码：1709 / 1718

页数：10

共 38 条

[1] Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis [J].

Andrabi, Shaida A. ;

Umanah, George K. E. ;

Chang, Calvin ;

Stevens, Daniel A. ;

Karuppagounder, Senthilkumar S. ;

Gagne, Jean-Philippe ;

Poirier, Guy G. ;

Dawson, Valina L. ;

Dawson, Ted M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (28) :10209-10214

[2] Glioblastoma Cells Containing Mutations in the Cohesin Component STAG2 Are Sensitive to PARP Inhibition [J].

Bailey, Melanie L. ;

O'Neil, Nigel J. ;

van Pel, Derek M. ;

Solomon, David A. ;

Waldman, Todd ;

Hieter, Philip .

MOLECULAR CANCER THERAPEUTICS, 2014, 13 (03) :724-732

[3] Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2 [J].

Borodovsky, Alexandra ;

Seltzer, Meghan J. ;

Riggins, Gregory J. .

CURRENT OPINION IN ONCOLOGY, 2012, 24 (01) :83-89

[4] Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG [J].

Buckner, Jan C. ;

Pugh, Stephanie L. ;

Shaw, Edward G. ;

Gilbert, Mark R. ;

Barger, Geoffrey ;

Coons, Stephen ;

Ricci, Peter ;

Bullard, Dennis ;

Brown, Paul D. ;

Stelzer, Keith ;

Brachman, David ;

Suh, John H. ;

Schultz, Christopher J. ;

Bahary, Jean-Paul ;

Fisher, Barbara Jean ;

Kim, Harold ;

Murtha, Albert D. ;

Curran, Walter J. ;

Mehta, Minesh P. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[5] Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH [J].

Cairncross, J. Gregory ;

Wang, Meihua ;

Jenkins, Robert B. ;

Shaw, Edward G. ;

Giannini, Caterina ;

Brachman, David G. ;

Buckner, Jan C. ;

Fink, Karen L. ;

Souhami, Luis ;

Laperriere, Normand J. ;

Huse, Jason T. ;

Mehta, Minesh P. ;

Curran, Walter J., Jr. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (08) :783-+

[6] Biosensor reveals multiple sources for mitochondrial NAD+ [J].

Cambronne, Xiaolu A. ;

Stewart, Melissa L. ;

Kim, DongHo ;

Jones-Brunette, Amber M. ;

Morgan, Rory K. ;

Farrens, David L. ;

Cohen, Michael S. ;

Goodman, Richard H. .

SCIENCE, 2016, 352 (6292) :1474-1477

[7] Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma [J].

Chen, Ruihuan ;

Nishimura, Merry C. ;

Kharbanda, Samir ;

Peale, Frank ;

Deng, Yuzhong ;

Daemen, Anneleen ;

Forrest, William F. ;

Kwong, Mandy ;

Hedehus, Maj ;

Hatzivassiliou, Georgia ;

Friedman, Lori S. ;

Phillips, Heidi S. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (39) :14217-14222

[8] Cancer-associated IDH1 mutations produce 2-hydroxyglutarate [J].

Dang, Lenny ;

White, David W. ;

Gross, Stefan ;

Bennett, Bryson D. ;

Bittinger, Mark A. ;

Driggers, Edward M. ;

Fantin, Valeria R. ;

Jang, Hyun Gyung ;

Jin, Shengfang ;

Keenan, Marie C. ;

Marks, Kevin M. ;

Prins, Robert M. ;

Ward, Patrick S. ;

Yen, Katharine E. ;

Liau, Linda M. ;

Rabinowitz, Joshua D. ;

Cantley, Lewis C. ;

Thompson, Craig B. ;

Heiden, Matthew G. Vander ;

Su, Shinsan M. .

NATURE, 2009, 462 (7274) :739-U52

[9] Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].

Farmer, H ;

McCabe, N ;

Lord, CJ ;

Tutt, ANJ ;

Johnson, DA ;

Richardson, TB ;

Santarosa, M ;

Dillon, KJ ;

Hickson, I ;

Knights, C ;

Martin, NMB ;

Jackson, SP ;

Smith, GCM ;

Ashworth, A .

NATURE, 2005, 434 (7035) :917-921

[10] ARTD1/PARP1 Negatively Regulates Glycolysis by Inhibiting Hexokinase 1 Independent of NAD+ Depletion [J].

Fouquerel, Elise ;

Goellner, Eva M. ;

Yu, Zhongxun ;

Gagne, Jean-Philippe ;

de Moura, Michelle Barbi ;

Feinstein, Tim ;

Wheeler, David ;

Redpath, Philip ;

Li, Jianfeng ;

Romero, Guillermo ;

Migaud, Marie ;

Van Houten, Bennett ;

Poirier, Guy G. ;

Sobol, Robert W. .

CELL REPORTS, 2014, 8 (06) :1819-1831

← 1 2 3 4 →